The Pill That Just Cut the Deadliest Cancer's Death Risk by 60% Finally Got FDA's Yes
The FDA has approved Rasonque, a new cancer pill, which nearly doubles survival rates in advanced pancreatic cancer patients, marking a significant advancement in treatment options.
International Business Times UK ·